Patient Engagement Solutions Market by Therapy, Functionality, End User, Unmet Need, Investment, Market Share, and Trends

Description

List of Tables

The patient engagement solutions market is projected to reach USD 51.69 billion by 2030 from USD 29.33 billion in 2025, at a CAGR of 12.0% during the forecast period. Factors such as the rising use of digital solutions that allow real-time communication, personalized interaction, and easy interfacing.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD billion)
Segments	Component, Delivery Mode, Therapeutic Area, Application, Functionality, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Latin America and Middle East & Africa

Others may include advancements such as cloud solutions, mobile solutions, and analytics. High investment requirements for healthcare infrastructure and a lack of skilled IT professionals in the healthcare sector are anticipated to impede the growth of this market .

Patient Engagement Solutions Market - IMG1

"Services segment is expected to grow at the highest rate during the forecast period."

By components, the patient engagement solutions market is divided into software, hardware, and services. The services segment is expected to grow at the fastest rate as healthcare organizations increasingly seek support for implementation, customization, integration with EHRs, change management, training, and ongoing optimization of engagement technologies. These professional and managed services help providers and payers maximize the value of engagement platforms, adapt to evolving clinical workflows, and ensure seamless deployment across complex healthcare environments .

"The on-premise segment is anticipated to dominate the Patient Engagement Solutions market in 2024"

By delivery modes, the patient engagement solutions market is categorized into on-premise and cloud-based/web-based modes. In 2024, the on-premise segment is expected to dominate because many healthcare organizations, especially large hospitals and health systems, prefer to maintain direct control over sensitive patient data and core clinical systems. On-premise deployments also align with established IT infrastructures, existing EHR environments, and stringent security and compliance requirements, making them a dominant choice for organizations prioritizing data governance and internal integration .

"Health management segment accounted for the largest share of the global patient engagement solutions market, by applications"

By application, the patient engagement solutions market is divided into health management, home health management, social and behavioral management, and financial health management. In 2024, the health management applications segment accounts held the largest share of the global patient engagement solutions market. It encompasses comprehensive care coordination, chronic disease management, and population health initiatives that rely heavily on engagement tools to maintain continuous patient communication. These solutions help providers and payers monitor patient outcomes, close care gaps, and support preventive care, making health management the dominant application driving adoption of engagement platforms .

"Providers' segment accounted for the largest share of the global patient engagement solutions market, by end user in 2024."

By end users, the patient engagement solutions market is divided into providers, payers, patients, and other end users. The providers are further bifurcated into hospitals and healthcare system, ambulatory care centers, home healthcare, and other providers. Moreover the payers is further divided into private and public. By end users, the providers' segment accounted for the largest share of the global patient engagement solutions market in 2024. The large share of this segment is due to increasing implementation of patient engagement solutions to curtail mounting healthcare costs, offer value-based care, and expand financial outcomes are factors that are driving the growth of this segment.

"North America to dominate the patient engagement solutions market

In 2024, North America dominated the global patient engagement solutions market by region. Factors such as favorable government initiatives and regulations, the imperative to reduce healthcare costs, the increasing prevalence of chronic diseases, and the presence of key market players contribute significantly to the growth of the patient engagement solutions market in North America. Strong regulatory frameworks promoting patient access, data interoperability, and value-based care, along with the presence of leading healthcare IT vendors and high healthcare spending, continue to drive market leadership in the region .

Breakdown of supply-side primary interviews, by company type, designation, and region:

By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
By Designation: C-level (44%), Director-level (35%), and Others (21%)
By Region: North America (46%), Europe (26%), Asia Pacific (18%), Latin America (7%), and Middle East & Africa (10%)

McKesson Corporation (US), Veradigm LLC (US), Oracle (US), athenahealth (US), Health Catalyst (US), GetWellNetwork, Inc. (US), Lincata, Inc. (US), Cognizant (US), TruBridge (US), Oneview Healthcare (Ireland), AdvancedMD, Inc. (US), Epic Systems Corporation (US), Harris Healthcare (US), Medical Information Technology, Inc. (US), Tebra Technologies, Inc. (US), Televox (US), Medhost (US), Nuance Communications, Inc. (US) (Microsoft), Solutionreach, Inc. (US), Experian Information Solutions, Inc. (US). These players are increasingly focusing on new product launches and partnerships to expand their product offerings in the patient engagement solutions market.

Research Coverage

The report studies the Patient Engagement Solutions market based on component, delivery mode, therapeutic area, application, functionality, end user, and region.
The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total patient engagement solutions market.
The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
Analysis of key drivers (implementation of government regulations and initiatives to promote patient centric care, increasing adoption of patient engagement solutions, rising number of collaborations and partnerships between stakeholders, increasing utilisation of mobile health apps, rising geriatric population and subsequent increase in prevalence of chronic diseases), restraints (large investment requirement for healthcare infrastructure, protection of patient information, inadequate interoperability across healthcare providers and shortage of skilled IT professionals in the healthcare industry ), opportunities (growth opportunities in emerging markets, wearable health technology, cloud computing solutions), and challenges (high deployment cost of healthcare IT systems, low levels of healthcare literacy) impacting the growth of the patient engagement solutions market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient engagement solutions market.
Market Development: Comprehensive information on the lucrative emerging markets, component, delivery mode, therapeutic area, application, functionality, end user, and region
Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient engagement solutions market
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global patient engagement market.

Product Code: HIT 2767

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

2.1 KEY INSIGHTS & MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

3.1 PATIENT ENGAGEMENT SOLUTIONS MARKET OVERVIEW
3.2 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE AND REGION
3.3 PATIENT ENGAGEMENT SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
  - 4.2.1.1 Increasing adoption of telehealth and remote care
  - 4.2.1.2 Increasing smartphone use and digital comfort
  - 4.2.1.3 Implementation of government regulations and initiatives to promote patient-centric care
  - 4.2.1.4 Growing prevalence of chronic diseases and rising demand for long-term patient involvement
- 4.2.2 RESTRAINTS
  - 4.2.2.1 Data privacy and cybersecurity concerns
  - 4.2.2.2 Inadequate interoperability across healthcare providers
  - 4.2.2.3 Shortage of skilled IT professionals in healthcare industry
- 4.2.3 OPPORTUNITIES
  - 4.2.3.1 Expansion of remote and home-based care models
  - 4.2.3.2 AI-driven personalization in patient engagement solutions
  - 4.2.3.3 Integration with wearables and personalized health tech
- 4.2.4 CHALLENGES
  - 4.2.4.1 Low patient adoption and engagement over time
  - 4.2.4.2 Fragmented data and siloed digital tools
4.3 UNMET NEEDS & WHITE SPACES
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 BARGAINING POWER OF SUPPLIERS
- 5.1.2 BARGAINING POWER OF BUYERS
- 5.1.3 THREAT OF SUBSTITUTES
- 5.1.4 THREAT OF NEW ENTRANTS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMICS OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
- 5.4.1 ROLE IN ECOSYSTEM
5.5 PRICING ANALYSIS
- 5.5.1 INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY COMPONENT, 2025
- 5.5.2 INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY REGION, 2025
5.6 TRADE ANALYSIS
- 5.6.1 IMPORT SCENARIO FOR HS CODE 8528, 2021-2024
- 5.6.2 IMPORT SCENARIO FOR HS CODE 8471, 2021-2024
- 5.6.3 EXPORT SCENARIO FOR HS CODE 8528, 2021-2024
- 5.6.4 EXPORT SCENARIO FOR HS CODE 8471, 2021-2024
5.7 KEY CONFERENCES AND EVENTS, 2026-2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.9 INVESTMENT & FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
- 5.10.1 ACHIEVING USD 15 MILLION IN SAVINGS BY REDUCING READMISSIONS WITH POST-DISCHARGE FOLLOW-UP
- 5.10.2 BUILD TRUST THROUGH PATIENT ENGAGEMENT TECHNOLOGY: CHILDREN'S HOSPITAL CASE STUDY
- 5.10.3 IMPROVING PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL WITH TRUBRIDGE PATIENT CONNECT
5.11 IMPACT OF 2025 US TARIFF ON PATIENT ENGAGEMENT SOLUTIONS MARKET
- 5.11.1 KEY TARIFF RATES
- 5.11.2 PRICE IMPACT ANALYSIS
- 5.11.3 IMPACT ON COUNTRY/REGION
  - 5.11.3.1 US
  - 5.11.3.2 Europe
  - 5.11.3.3 Asia Pacific
- 5.11.4 IMPACT ON END-USE INDUSTRIES
  - 5.11.4.1 Hospitals and healthcare systems
  - 5.11.4.2 ASCs, ACCs, and other outpatient settings
  - 5.11.4.3 Home healthcare providers
  - 5.11.4.4 Private payers
  - 5.11.4.5 Public payers
  - 5.11.4.6 Other end users

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

6.1 KEY EMERGING TECHNOLOGIES
- 6.1.1 CLOUD COMPUTING
- 6.1.2 API & EHR INTEGRATION TECHNOLOGIES
- 6.1.3 DATA ANALYTICS
6.2 COMPLEMENTARY TECHNOLOGIES
- 6.2.1 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML)
- 6.2.2 CONVERSATIONAL AI/CHATBOTS
- 6.2.3 BEHAVIORAL ANALYTICS AND PERSONALIZATION ENGINES
6.3 ADJACENT TECHNOLOGIES
- 6.3.1 CYBERSECURITY AND DATA ENCRYPTION
- 6.3.2 BLOCKCHAIN
- 6.3.3 BIG DATA AND ADVANCED ANALYTICS
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.5 PATENT ANALYSIS
- 6.5.1 PATENT PUBLICATION TRENDS FOR PATIENT ENGAGEMENT SOLUTION
- 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
- 6.5.3 LIST OF PATENTS/PATENT APPLICATIONS
6.6 FUTURE APPLICATIONS
- 6.6.1 AI-DRIVEN PREDICTIVE ENGAGEMENT
- 6.6.2 CONTINUOUS REMOTE CARE AND HOSPITAL-AT-HOME ENABLEMENT
- 6.6.3 PERSONALIZED DIGITAL THERAPEUTICS AND BEHAVIORAL COACHING
- 6.6.4 CLOSED-LOOP CARE COORDINATION AND VALUE-BASED PERFORMANCE OPTIMIZATION
- 6.6.5 DECENTRALIZED CLINICAL TRIALS AND REAL-WORLD EVIDENCE GENERATION
6.7 IMPACT OF AI/GEN AI ON PATIENT ENGAGEMENT SOLUTIONS MARKET
- 6.7.1 INTRODUCTION
- 6.7.2 MARKET POTENTIAL OF AI/GEN AI IN PATIENT ENGAGEMENT SOLUTIONS MARKET
- 6.7.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
  - 6.7.3.1 AI-driven conversational AI for pre/post-op engagement
- 6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  - 6.7.4.1 Patient communication & virtual care platforms
  - 6.7.4.2 Remote patient monitoring & digital therapeutics
  - 6.7.4.3 Population health & health equity programs
- 6.7.5 USER READINESS AND IMPACT ASSESSMENT
  - 6.7.5.1 User readiness
    - 6.7.5.1.1 User A: Hospitals & clinics
    - 6.7.5.1.2 User B: Healthcare providers, employers, and forensic agencies
  - 6.7.5.2 Impact assessment
    - 6.7.5.2.1 User A: Clinical, reference, and toxicology laboratories
    - 6.7.5.2.2 User B: Healthcare providers, employers, and forensic agencies

7 REGULATORY LANDSCAPE

7.1 REGIONAL REGULATIONS & COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 REGULATORY FRAMEWORK
  - 7.1.2.1 North America
  - 7.1.2.2 Europe
  - 7.1.2.3 Asia Pacific
  - 7.1.2.4 Latin America
  - 7.1.2.5 Middle East & Africa
- 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

8.1 INTRODUCTION
8.2 DECISION-MAKING PROCESS
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
- 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.3.2 BUYING CRITERIA
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.5 UNMET NEEDS/END-USER EXPECTATIONS
- 8.5.1 UNMET NEEDS
- 8.5.2 END-USER EXPECTATIONS
8.6 MARKET PROFITIBILITY

9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT

9.1 INTRODUCTION
9.2 HARDWARE
- 9.2.1 IN-ROOM TELEVISIONS
  - 9.2.1.1 Rising patient demand for real-time health transparency and smart room modernization initiatives to drive market
- 9.2.2 INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES
  - 9.2.2.1 Hospitals to increasingly adopt bedside terminals to address workforce shortages and reduce nursing workload
- 9.2.3 TABLETS
  - 9.2.3.1 Strong ROI profile, lower upfront investment, and rapid rollout capability to propel market growth
9.3 SOFTWARE
- 9.3.1 PRE-CARE ENGAGEMENT
  - 9.3.1.1 Increasing adoption of consumer-centric access models to aid segment growth
- 9.3.2 POINT-OF-CARE ENGAGEMENT
  - 9.3.2.1 Exponential growth in healthcare data and rising information complexity to augment segment growth
- 9.3.3 POST-CARE ENGAGEMENT
  - 9.3.3.1 Shift toward value-based care and reimbursement models for readmission rates to drive segment growth
9.4 SERVICES
- 9.4.1 IMPLEMENTATION & INTEGRATION SERVICES
  - 9.4.1.1 Need for expertise to operationalize sophisticated patient engagement ecosystems to fuel market growth
- 9.4.2 TRAINING & EDUCATION SERVICES
  - 9.4.2.1 Need to eradicate measurable staff usability challenges and patient digital access gaps to drive segment
- 9.4.3 SUPPORT & MAINTENANCE SERVICES
  - 9.4.3.1 Dependency on patient portals, telehealth systems, and integrated EHR infrastructures to aid market growth
- 9.4.4 CONSULTING SERVICES
  - 9.4.4.1 Shift from volume-based to value-based care models to drive consulting services market

10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE

10.1 INTRODUCTION
10.2 ON-PREMISES
- 10.2.1 ON-PREMISES ADOPTION TO ACCELERATE AMID SECURITY, REGULATORY, AND INTEGRATION PRIORITIES
10.3 CLOUD-BASED
- 10.3.1 CLOUD-BASED PATIENT ENGAGEMENT TO PROPEL SCALABLE, SECURE, AND INTEROPERABLE CARE

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION

11.1 INTRODUCTION
11.2 CLINICAL CARE
- 11.2.1 VALUE-BASED CARE MODELS AND TELEHEALTH EXPANSION TO PROPEL CLINICAL CARE SEGMENT
11.3 CARE COORDINATION & COMMUNICATION
- 11.3.1 FRAGMENTED CARE PATHWAYS AND INTEROPERABILITY MANDATES TO ACCELERATE MARKET GROWTH
11.4 HOME & REMOTE CARE
- 11.4.1 HOSPITAL-AT-HOME EXPANSION, READMISSION PENALTIES, AND RPM REIMBURSEMENT TO FUEL SEGMENT GROWTH
11.5 POPULATION HEALTH & BEHAVIORAL ENGAGEMENT
- 11.5.1 VALUE-BASED CARE MANDATES, RISK STRATIFICATION, AND BEHAVIORAL HEALTH INTEGRATION TO PROPEL SEGMENT GROWTH
11.6 FINANCIAL ENGAGEMENT
- 11.6.1 RISING OUT-OF-POCKET COSTS, CONSUMERISM, AND REVENUE PRESSURE TO DRIVE FINANCIAL ENGAGEMENT ADOPTION
11.7 OTHER APPLICATIONS

12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA

12.1 INTRODUCTION
12.2 CHRONIC DISEASES
- 12.2.1 CARDIOVASCULAR DISEASES
  - 12.2.1.1 Need for continuous monitoring and preventive engagement through digital health platforms to drive market
- 12.2.2 DIABETES
  - 12.2.2.1 Continuous glucose monitoring, behavioral adherence, and data-driven self-management through digital engagement to drive market
- 12.2.3 OBESITY
  - 12.2.3.1 Preventive engagement, behavioral modification, and long-term risk reduction through digital health platforms to drive market
- 12.2.4 RESPIRATORY DISORDERS
  - 12.2.4.1 Advancing continuous symptom monitoring and preventive care through digital engagement platforms to fuel market growth
- 12.2.5 ONCOLOGY
  - 12.2.5.1 Longitudinal care coordination, symptom monitoring, and survivorship engagement to boost market
- 12.2.6 OTHER CHRONIC DISEASES
12.3 WOMEN'S HEALTH
- 12.3.1 PREVENTIVE SCREENING, REPRODUCTIVE CARE COORDINATION, AND LIFECYCLE ENGAGEMENT TO AID MARKET GROWTH
12.4 BEHAVIORAL & MENTAL HEALTH
- 12.4.1 INCREASING GLOBAL PREVALENCE OF DEPRESSION, ANXIETY, SUBSTANCE USE DISORDERS TO AID MARKET GROWTH
12.5 OTHER THERAPEUTIC AREAS

13 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY

13.1 INTRODUCTION
13.2 PATIENT/CLIENT SCHEDULING
- 13.2.1 DIGITAL-FIRST, MOBILE-DRIVEN SCHEDULING TO REDUCE NO-SHOWS AND STRENGTHEN ACCESS PERFORMANCE
13.3 TELEHEALTH
- 13.3.1 TELEHEALTH TO DRIVE QUALITY IMPROVEMENT AND HYBRID CARE DELIVERY GROWTH
13.4 E-PRESCRIBING
- 13.4.1 E-PRESCRIBING TO STRENGTHEN MEDICATION SAFETY REGULATORY COMPLIANCE
13.5 DOCUMENT MANAGEMENT
- 13.5.1 DIGITAL RECORD ACCESS TO DRIVE DOCUMENT MANAGEMENT IN CORE PATIENT ENGAGEMENT INFRASTRUCTURE
13.6 BILLING & PAYMENTS
- 13.6.1 RISING PATIENT FINANCIAL RESPONSIBILITY AND GROWING DEMAND FOR DIGITAL TRANSPARENCY TO DRIVE MARKET
13.7 PATIENT EDUCATION
- 13.7.1 SELF-DIRECTED HEALTH RESEARCH AND DIGITAL LITERACY GAPS TO RISE DEMAND FOR INTEGRATED PATIENT EDUCATION TOOLS
13.8 OTHER FUNCTIONALITIES

14 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER

14.1 INTRODUCTION
14.2 PROVIDERS
- 14.2.1 HOSPITALS & HEALTHCARE SYSTEMS
  - 14.2.1.1 Healthcare systems to drive patient experience and operational efficiency through integrated patient engagement solutions
- 14.2.2 ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS
  - 14.2.2.1 Need for optimizing patient access and engagement in outpatient care settings to propel segment growth
- 14.2.3 HOME HEALTHCARE PROVIDERS
  - 14.2.3.1 Home healthcare provides to enhance patient engagement and remote care delivery in home settings
- 14.2.4 OTHER PROVIDERS
14.3 PAYERS
- 14.3.1 PRIVATE PAYERS
  - 14.3.1.1 Private payers to enhance member experience and cost efficiency through digital-first engagement strategies
- 14.3.2 PUBLIC PAYERS
  - 14.3.2.1 Public payers to strengthen population health management through inclusive and scalable digital engagement
14.4 OTHER END USERS

15 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION

15.1 INTRODUCTION
15.2 NORTH AMERICA
- 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 15.2.2 US
  - 15.2.2.1 Value-based care reforms and long-term care management need to accelerate market growth
- 15.2.3 CANADA
  - 15.2.3.1 Government policies to strengthen digital health infrastructure and interoperability
15.3 EUROPE
- 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 15.3.2 GERMANY
  - 15.3.2.1 Nationwide ePA rollout and digital therapeutics leadership to propel market growth
- 15.3.3 FRANCE
  - 15.3.3.1 Near-universal digital health record adoption and strategic investment to aid market growth
- 15.3.4 UK
  - 15.3.4.1 NHS app scale-up and virtual care expansion to boost market growth
- 15.3.5 ITALY
  - 15.3.5.1 Rising digital health investment and growing focus on national telemedicine infrastructure to fuel market growth
- 15.3.6 SPAIN
  - 15.3.6.1 Rising telemedicine expansion and growing mHealth adoption to strengthen market
- 15.3.7 REST OF EUROPE
15.4 ASIA PACIFIC
- 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 15.4.2 CHINA
  - 15.4.2.1 High digital health adoption and internet hospital expansion to accelerate market growth
- 15.4.3 JAPAN
  - 15.4.3.1 Healthcare digitalization to accelerate patient engagement in Japan
- 15.4.4 INDIA
  - 15.4.4.1 Digital public health infrastructure and mobile penetration to augment market growth
- 15.4.5 SOUTH KOREA
  - 15.4.5.1 National digital integration and rapid population aging to aid market growth
- 15.4.6 AUSTRALIA
  - 15.4.6.1 Near-universal digital records and embedded telehealth adoption to fuel market growth
- 15.4.7 REST OF ASIA PACIFIC
15.5 LATIN AMERICA
- 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 15.5.2 BRAZIL
  - 15.5.2.1 Government-led telehealth scale and institutionalized patient participation to propel digital engagement
- 15.5.3 MEXICO
  - 15.5.3.1 Structural health system gaps to spur digital patient engagement adoption
- 15.5.4 REST OF LATIN AMERICA
15.6 MIDDLE EAST & AFRICA
- 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 15.6.2 GCC COUNTRIES
  - 15.6.2.1 High NCD burden and government-owned digital platforms to augment patient engagement
  - 15.6.2.2 Kingdom of Saudi Arabia
    - 15.6.2.2.1 Government-led digital health innovations to accelerate patient engagement
  - 15.6.2.3 UAE
    - 15.6.2.3.1 Progressive digital health innovations to strengthen UAE patient engagement solutions market
  - 15.6.2.4 Rest of GCC countries
- 15.6.3 SOUTH AFRICA
  - 15.6.3.1 Massive telemedicine adoption and innovative digital platforms to aid market growth
- 15.6.4 REST OF MIDDLE EAST & AFRICA

16 COMPETITIVE LANDSCAPE

16.1 INTRODUCTION
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 16.2.1 OVERVIEW OF KEY STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
16.3 REVENUE ANALYSIS, 2020-2024
16.4 MARKET SHARE ANALYSIS, 2024
16.5 BRAND COMPARISON
16.6 COMPANY VALUATION & FINANCIAL METRICS
- 16.6.1 FINANCIAL METRICS
- 16.6.2 COMPANY VALUATION
16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 16.7.1 STARS
- 16.7.2 EMERGING LEADERS
- 16.7.3 PERVASIVE PLAYERS
- 16.7.4 PARTICIPANTS
- 16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
  - 16.7.5.1 Company footprint
  - 16.7.5.2 Region footprint
  - 16.7.5.3 Component footprint
  - 16.7.5.4 Application footprint
  - 16.7.5.5 End-user footprint
16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 16.8.1 PROGRESSIVE COMPANIES
- 16.8.2 RESPONSIVE COMPANIES
- 16.8.3 DYNAMIC COMPANIES
- 16.8.4 STARTING BLOCKS
- 16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  - 16.8.5.1 Detailed list of key startups/SMEs
  - 16.8.5.2 Competitive benchmarking of startups/SMEs
16.9 COMPETITIVE SCENARIO
- 16.9.1 PRODUCT LAUNCHES & ENHANCEMENTS
- 16.9.2 DEALS
- 16.9.3 EXPANSIONS
- 16.9.4 OTHER DEVELOPMENTS

17 COMPANY PROFILES

17.1 KEY PLAYERS
- 17.1.1 MCKESSON CORPORATION
  - 17.1.1.1 Business overview
  - 17.1.1.2 Products offered
  - 17.1.1.3 Recent developments
    - 17.1.1.3.1 Deals
  - 17.1.1.4 MnM view
    - 17.1.1.4.1 Right to win
    - 17.1.1.4.2 Strategic choices
    - 17.1.1.4.3 Weaknesses & competitive threats
- 17.1.2 ORACLE
  - 17.1.2.1 Business overview
  - 17.1.2.2 Products offered
  - 17.1.2.3 Recent developments
    - 17.1.2.3.1 Product launches
    - 17.1.2.3.2 Deals
  - 17.1.2.4 MnM view
    - 17.1.2.4.1 Right to win
    - 17.1.2.4.2 Strategic choices
    - 17.1.2.4.3 Weaknesses & competitive threats
- 17.1.3 MICROSOFT (NUANCE COMMUNICATIONS, INC.)
  - 17.1.3.1 Business overview
  - 17.1.3.2 Products offered
  - 17.1.3.3 Recent developments
    - 17.1.3.3.1 Product launches
    - 17.1.3.3.2 Deals
  - 17.1.3.4 MnM view
    - 17.1.3.4.1 Right to win
    - 17.1.3.4.2 Strategic choices
    - 17.1.3.4.3 Weaknesses & competitive threats
- 17.1.4 TRUBRIDGE
  - 17.1.4.1 Business overview
  - 17.1.4.2 Products offered
  - 17.1.4.3 Recent developments
    - 17.1.4.3.1 Deals
  - 17.1.4.4 MnM view
    - 17.1.4.4.1 Right to win
    - 17.1.4.4.2 Strategic choices
    - 17.1.4.4.3 Weaknesses & competitive threats
- 17.1.5 HEALTH CATALYST
  - 17.1.5.1 Business overview
  - 17.1.5.2 Products offered
  - 17.1.5.3 Recent developments
    - 17.1.5.3.1 Deals
  - 17.1.5.4 MnM view
    - 17.1.5.4.1 Right to win
    - 17.1.5.4.2 Strategic choices
    - 17.1.5.4.3 Weaknesses & competitive threats
- 17.1.6 VERADIGM LLC
  - 17.1.6.1 Business overview
  - 17.1.6.2 Products offered
  - 17.1.6.3 Recent developments
    - 17.1.6.3.1 Product launches
    - 17.1.6.3.2 Deals
- 17.1.7 ATHENAHEALTH
  - 17.1.7.1 Business overview
  - 17.1.7.2 Products offered
  - 17.1.7.3 Recent developments
    - 17.1.7.3.1 Product launches and enhancements
    - 17.1.7.3.2 Deals
    - 17.1.7.3.3 Other developments
- 17.1.8 GETWELLNETWORK, INC.
  - 17.1.8.1 Business overview
  - 17.1.8.2 Products offered
  - 17.1.8.3 Recent developments
    - 17.1.8.3.1 Product enhancements
    - 17.1.8.3.2 Deals
- 17.1.9 LINCATA, INC.
  - 17.1.9.1 Business overview
  - 17.1.9.2 Products offered
- 17.1.10 COGNIZANT
  - 17.1.10.1 Business overview
  - 17.1.10.2 Products offered
  - 17.1.10.3 Recent developments
    - 17.1.10.3.1 Deals
- 17.1.11 ONEVIEW HEALTHCARE
  - 17.1.11.1 Business overview
  - 17.1.11.2 Products offered
  - 17.1.11.3 Recent developments
    - 17.1.11.3.1 Product launches and enhancements
    - 17.1.11.3.2 Deals
    - 17.1.11.3.3 Other developments
- 17.1.12 ADVANCEDMD, INC.
  - 17.1.12.1 Business overview
  - 17.1.12.2 Products offered
  - 17.1.12.3 Recent developments
    - 17.1.12.3.1 Product enhancements
    - 17.1.12.3.2 Deals
- 17.1.13 EPIC SYSTEMS CORPORATION
  - 17.1.13.1 Business overview
  - 17.1.13.2 Products offered
  - 17.1.13.3 Recent developments
    - 17.1.13.3.1 Product enhancement
    - 17.1.13.3.2 Deals
- 17.1.14 HARRIS HEALTHCARE
  - 17.1.14.1 Business overview
  - 17.1.14.2 Products offered
  - 17.1.14.3 Recent developments
    - 17.1.14.3.1 Deals
- 17.1.15 MEDICAL INFORMATION TECHNOLOGY, INC.
  - 17.1.15.1 Business overview
  - 17.1.15.2 Products offered
  - 17.1.15.3 Recent developments
    - 17.1.15.3.1 Deals
    - 17.1.15.3.2 Other developments
- 17.1.16 TEBRA TECHNOLOGIES, INC.
  - 17.1.16.1 Business overview
  - 17.1.16.2 Products offered
  - 17.1.16.3 Recent developments
    - 17.1.16.3.1 Product enhancements
    - 17.1.16.3.2 Deals
- 17.1.17 TELEVOX
  - 17.1.17.1 Business overview
  - 17.1.17.2 Products offered
  - 17.1.17.3 Recent developments
    - 17.1.17.3.1 Product launches
    - 17.1.17.3.2 Deals
- 17.1.18 SOLUTIONREACH, INC.
  - 17.1.18.1 Business overview
  - 17.1.18.2 Products offered
  - 17.1.18.3 Recent developments
    - 17.1.18.3.1 Product launches and enhancements
- 17.1.19 EXPERIAN INFORMATION SOLUTIONS, INC.
  - 17.1.19.1 Business overview
  - 17.1.19.2 Products offered
- 17.1.20 ECLINICALWORKS
  - 17.1.20.1 Business overview
  - 17.1.20.2 Products offered
17.2 OTHER PLAYERS
- 17.2.1 WELLSTACK
- 17.2.2 RELATIENT
- 17.2.3 LUMA HEALTH INC.
- 17.2.4 CIPHERHEALTH INC.
- 17.2.5 YOSI HEALTH

18 RESEARCH METHODOLOGY

18.1 RESEARCH APPROACH
- 18.1.1 SECONDARY RESEARCH
  - 18.1.1.1 Key secondary sources
  - 18.1.1.2 Key data from secondary sources
- 18.1.2 PRIMARY RESEARCH
  - 18.1.2.1 Primary sources
  - 18.1.2.2 Key objectives of primary research
  - 18.1.2.3 Key data from primary sources
  - 18.1.2.4 Breakdown of primaries
  - 18.1.2.5 Insights from primary experts
18.2 RESEARCH METHODOLOGY DESIGN
18.3 MARKET SIZE ESTIMATION
- 18.3.1 BOTTOM-UP APPROACH (REVENUE SHARE ANALYSIS)
- 18.3.2 TOP-DOWN OF PARENT MARKET ASSESSMENT
- 18.3.3 PRIMARY INTERVIEWS
- 18.3.4 TOP-DOWN APPROACH
18.4 DATA TRIANGULATION
18.5 MARKET SHARE ESTIMATION
18.6 STUDY ASSUMPTIONS
18.7 RESEARCH LIMITATIONS
18.8 RISK ANALYSIS

19 APPENDIX

19.1 DISCUSSION GUIDE
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
19.3 CUSTOMIZATION OPTIONS
19.4 RELATED REPORTS
19.5 AUTHOR DETAILS

Product Code: HIT 2767

List of Tables

TABLE 1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
TABLE 3 IMPACT OF PORTER'S FIVE FORCES ON PATIENT ENGAGEMENT SOLUTIONS MARKET
TABLE 4 ROLE OF COMPANIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET ECOSYSTEM
TABLE 5 INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY COMPONENT, 2025 (USD)
TABLE 6 INDICATIVE PRICE FOR PATIENT ENGAGEMENT SOLUTIONS, BY REGION, 2025 (USD)
TABLE 7 IMPORT SCENARIO FOR HS CODE 8528, 2021-2024 (USD THOUSAND)
TABLE 8 IMPORT SCENARIO FOR HS CODE 8741, 2021-2024 (USD THOUSAND)
TABLE 9 EXPORT SCENARIO FOR HS CODE 8528, 2021-2024 (USD THOUSAND)
TABLE 10 EXPORT SCENARIO FOR HS CODE 8471, 2021-2024 (USD THOUSAND)
TABLE 11 LIST OF KEY CONFERENCES AND EVENTS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, JANUARY 2026-DECEMBER 2027
TABLE 12 CASE STUDY 1: ACHIEVING USD 15 MILLION IN SAVINGS BY REDUCING READMISSIONS WITH POST-DISCHARGE FOLLOW-UP
TABLE 13 CASE STUDY 2: BUILD TRUST THROUGH PATIENT ENGAGEMENT TECHNOLOGY: A CHILDREN'S HOSPITAL CASE STUDY
TABLE 14 CASE STUDY 3: IMPROVING PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL WITH TRUBRIDGE PATIENT CONNECT
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 16 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR PATIENT ENGAGEMENT SOLUTIONS MARKET
TABLE 17 LIST OF PATENTS/PATENT APPLICATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 REGULATORY SCENARIO OF NORTH AMERICA
TABLE 24 REGULATORY SCENARIO OF EUROPE
TABLE 25 REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 26 REGULATORY SCENARIO OF LATIN AMERICA
TABLE 27 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF MAJOR END USERS (%)
TABLE 29 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 30 UNMET NEEDS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
TABLE 31 END-USER EXPECTATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
TABLE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 33 LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT HARDWARE MARKET
TABLE 34 PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 35 PATIENT ENGAGEMENT HARDWARE MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 36 PATIENT ENGAGEMENT HARDWARE MARKET FOR IN-ROOM TELEVISIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 37 PATIENT ENGAGEMENT HARDWARE MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 38 PATIENT ENGAGEMENT HARDWARE MARKET FOR TABLETS, BY REGION, 2024-2031 (USD MILLION)
TABLE 39 LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOFTWARE MARKET
TABLE 40 PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 41 PATIENT ENGAGEMENT SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 42 PATIENT ENGAGEMENT SOFTWARE MARKET FOR PRE-CARE ENGAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 43 PATIENT ENGAGEMENT SOFTWARE MARKET FOR POINT-OF-CARE ENGAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 44 PATIENT ENGAGEMENT SOFTWARE MARKET FOR POST-CARE ENGAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 45 LIST OF PRODUCTS OFFERED BY KEY PLAYERS IN PATIENT ENGAGEMENT SERVICES MARKET
TABLE 46 PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 47 PATIENT ENGAGEMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 48 PATIENT ENGAGEMENT SERVICES MARKET FOR IMPLEMENTATION & INTEGRATION SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 49 PATIENT ENGAGEMENT SERVICES MARKET FOR TRAINING & EDUCATION SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 50 PATIENT ENGAGEMENT SERVICES MARKET FOR SUPPORT & MAINTENANCE SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 51 PATIENT ENGAGEMENT SERVICES MARKET FOR CONSULTING SERVICES, BY REGION, 2024-2031 (USD MILLION)
TABLE 52 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 53 KEY COMPANIES OFFERING ON-PREMISES PATIENT ENGAGEMENT SOLUTIONS
TABLE 54 ON-PREMISES PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 55 KEY COMPANIES OFFERING CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS
TABLE 56 CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 57 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 58 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CLINICAL CARE
TABLE 59 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLINICAL CARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 60 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CARE COORDINATION & COMMUNICATION
TABLE 61 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARE COORDINATION & COMMUNICATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 62 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR HOME & REMOTE CARE
TABLE 63 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME & REMOTE CARE, BY REGION, 2024-2031 (USD MILLION)
TABLE 64 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR POPULATION HEALTH & BEHAVIORAL ENGAGEMENT
TABLE 65 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR POPULATION HEALTH & BEHAVIORAL ENGAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 66 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR FINANCIAL ENGAGEMENT
TABLE 67 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL ENGAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 68 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER APPLICATIONS
TABLE 69 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
TABLE 70 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 71 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR CHRONIC DISEASES
TABLE 72 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 73 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2024-2031 (USD MILLION)
TABLE 74 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2024-2031 (USD MILLION)
TABLE 75 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2024-2031 (USD MILLION)
TABLE 76 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2024-2031 (USD MILLION)
TABLE 77 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR RESPIRATORY DISORDERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 78 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ONCOLOGY, BY REGION, 2024-2031 (USD MILLION)
TABLE 79 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2024-2031 (USD MILLION)
TABLE 80 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR WOMEN'S HEALTH
TABLE 81 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN'S HEALTH, BY REGION, 2024-2031 (USD MILLION)
TABLE 82 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR BEHAVIORAL & MENTAL HEALTH
TABLE 83 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BEHAVIORAL & MENTAL HEALTH, BY REGION, 2024-2031 (USD MILLION)
TABLE 84 MAJOR PLAYERS OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER THERAPEUTIC AREAS
TABLE 85 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2024-2031 (USD MILLION)
TABLE 86 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 87 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR PATIENT/CLIENT SCHEDULING
TABLE 88 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2024-2031 (USD MILLION)
TABLE 89 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR TELEHEALTH
TABLE 90 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY REGION, 2024-2031 (USD MILLION)
TABLE 91 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR E-PRESCRIBING
TABLE 92 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY REGION, 2024-2031 (USD MILLION)
TABLE 93 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR DOCUMENT MANAGEMENT
TABLE 94 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2024-2031 (USD MILLION)
TABLE 95 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR BILLING & PAYMENTS
TABLE 96 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY REGION, 2024-2031 (USD MILLION)
TABLE 97 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR PATIENT EDUCATION
TABLE 98 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY REGION, 2024-2031 (USD MILLION)
TABLE 99 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS FOR OTHER FUNCTIONALITIES
TABLE 100 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 101 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 102 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO PAYERS
TABLE 103 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 104 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 105 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
TABLE 106 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2024-2031 (USD MILLION)
TABLE 107 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTHCARE PROVIDERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 108 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 109 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO PAYERS
TABLE 110 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 111 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 112 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 113 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 114 MAJOR COMPANIES OFFERING PATIENT ENGAGEMENT SOLUTIONS TO OTHER END USERS
TABLE 115 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
TABLE 116 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 117 NORTH AMERICA: KEY MACROINDICATORS
TABLE 118 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 119 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 120 NORTH AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 121 NORTH AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 122 NORTH AMERICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 123 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 124 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 125 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 126 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 127 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 128 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 129 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 130 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 131 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 132 US: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 133 US: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 134 US: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 135 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 136 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 137 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 138 US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 139 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 140 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 141 US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 142 US: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 143 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 144 CANADA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 145 CANADA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 146 CANADA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 147 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 148 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 149 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 150 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 151 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 152 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 153 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 154 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 155 EUROPE: KEY MACROINDICATORS
TABLE 156 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 157 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 158 EUROPE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 159 EUROPE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 160 EUROPE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 161 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 162 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 163 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 164 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 165 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 166 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 167 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 168 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 169 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 170 GERMANY: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 171 GERMANY: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 172 GERMANY: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 173 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 174 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 175 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 176 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 177 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 178 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 179 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 180 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 181 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 182 FRANCE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 183 FRANCE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 184 FRANCE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 185 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 186 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 187 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 188 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 189 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 190 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 191 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 192 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 193 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 194 UK: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 UK: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 196 UK: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 197 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 198 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 199 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 200 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 201 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 202 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 203 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 204 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 205 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 206 ITALY: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 207 ITALY: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 208 ITALY: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 209 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 210 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 211 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 212 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 213 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 214 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 215 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 216 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 217 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 218 SPAIN: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 219 SPAIN: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 220 SPAIN: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 221 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 222 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 223 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 224 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 225 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 226 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 227 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 228 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 229 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 230 REST OF EUROPE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 231 REST OF EUROPE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 232 REST OF EUROPE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 233 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 234 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 235 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 236 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 237 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 238 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 239 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 240 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 241 ASIA PACIFIC: KEY MACROINDICATORS
TABLE 242 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 243 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 244 ASIA PACIFIC: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 245 ASIA PACIFIC: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 246 ASIA PACIFIC: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 247 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 248 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 249 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 250 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 251 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 252 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 253 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 254 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 255 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 256 CHINA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 257 CHINA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 258 CHINA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 259 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 260 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 261 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 262 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 263 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 264 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 265 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 266 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 267 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 268 JAPAN: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 269 JAPAN: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 270 JAPAN: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 271 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 272 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 273 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 274 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 275 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 276 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 277 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 278 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 279 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 280 INDIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 281 INDIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 282 INDIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 283 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 284 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 285 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 286 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 287 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 288 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 289 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 290 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 291 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 292 SOUTH KOREA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 293 SOUTH KOREA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 294 SOUTH KOREA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 295 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 296 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 297 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 298 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 299 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 300 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 301 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 302 SOUTH KOREA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 303 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 304 AUSTRALIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 305 AUSTRALIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 306 AUSTRALIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 307 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 308 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 309 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 310 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 311 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 312 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 313 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 314 AUSTRALIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 315 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 316 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 317 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 318 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 319 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 320 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 321 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 322 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 323 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 324 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 325 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 326 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 327 LATIN AMERICA: KEY MACROINDICATORS
TABLE 328 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 329 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 330 LATIN AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 331 LATIN AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 332 LATIN AMERICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 333 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 334 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 335 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 336 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 337 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 338 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 339 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 340 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 341 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 342 BRAZIL: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 343 BRAZIL: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 344 BRAZIL: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 345 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 346 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 347 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 348 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 349 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 350 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 351 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 352 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 353 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 354 MEXICO: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 355 MEXICO: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 356 MEXICO: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 357 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 358 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 359 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 360 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 361 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 362 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 363 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 364 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 365 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 366 REST OF LATIN AMERICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 367 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 368 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 369 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 370 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 371 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 372 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 373 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 374 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 375 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 376 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 377 MIDDLE EAST & AFRICA: KEY MACROINDICATORS
TABLE 378 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 379 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 380 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 381 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 382 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 383 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 384 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 385 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 386 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 387 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 388 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 389 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 390 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 391 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 392 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 393 GCC COUNTRIES: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 394 GCC COUNTRIES: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 395 GCC COUNTRIES: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 396 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 397 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 398 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 399 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 400 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 401 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 402 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 403 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 404 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 405 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 406 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 407 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 408 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 409 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 410 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 411 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 412 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 413 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 414 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 415 KINGDOM OF SAUDI ARABIA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 416 UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 417 UAE: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 418 UAE: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 419 UAE: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 420 UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 421 UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 422 UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 423 UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 424 UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 425 UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 426 UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 427 UAE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 428 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 429 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 430 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 431 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 432 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 433 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 434 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 435 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 436 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 437 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 438 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 439 REST OF GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 440 SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 441 SOUTH AFRICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 442 SOUTH AFRICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 443 SOUTH AFRICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 444 SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 445 SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 446 SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 447 SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 448 SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 449 SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 450 SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 451 SOUTH AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 452 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
TABLE 453 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT HARDWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 454 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 455 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SERVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 456 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
TABLE 457 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 458 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 459 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2024-2031 (USD MILLION)
TABLE 460 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
TABLE 461 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 462 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 463 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 464 OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, JANUARY 2022-FEBRUARY 2026
TABLE 465 PATIENT ENGAGEMENT SOLUTIONS MARKET: DEGREE OF COMPETITION
TABLE 466 PATIENT ENGAGEMENT SOLUTIONS MARKET: REGION FOOTPRINT
TABLE 467 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPONENT FOOTPRINT
TABLE 468 PATIENT ENGAGEMENT SOLUTIONS MARKET: APPLICATION FOOTPRINT
TABLE 469 PATIENT ENGAGEMENT SOLUTIONS MARKET: END-USER FOOTPRINT
TABLE 470 PATIENT ENGAGEMENT SOLUTIONS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 471 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS/STARTUP PLAYERS, BY REGION
TABLE 472 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY COMPONENT
TABLE 473 PATIENT ENGAGEMENT SOLUTIONS MARKET: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 474 PATIENT ENGAGEMENT SOLUTIONS MARKET: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 475 PATIENT ENGAGEMENT SOLUTIONS MARKET: EXPANSIONS, JANUARY 2022-FEBRUARY 2026
TABLE 476 PATIENT ENGAGEMENT SOLUTIONS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 477 MCKESSON CORPORATION: COMPANY OVERVIEW
TABLE 478 MCKESSON CORPORATION: PRODUCTS OFFERED
TABLE 479 MCKESSON CORPORATION: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 480 ORACLE: COMPANY OVERVIEW
TABLE 481 ORACLE: PRODUCTS OFFERED
TABLE 482 ORACLE: PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2026
TABLE 483 ORACLE: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 484 MICROSOFT (NUANCE COMMUNICATIONS, INC.): COMPANY OVERVIEW
TABLE 485 MICROSOFT (NUANCE COMMUNICATIONS, INC.): PRODUCTS OFFERED
TABLE 486 MICROSOFT (NUANCE COMMUNICATIONS, INC.): PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2026
TABLE 487 MICROSOFT (NUANCE COMMUNICATIONS, INC.): DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 488 TRUBRIDGE: COMPANY OVERVIEW
TABLE 489 TRUBRIDGE: PRODUCTS OFFERED
TABLE 490 TRUBRIDGE: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 491 HEALTH CATALYST: COMPANY OVERVIEW
TABLE 492 HEALTH CATALYST: PRODUCTS OFFERED
TABLE 493 HEALTH CATALYST: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 494 VERADIGM LLC: COMPANY OVERVIEW
TABLE 495 VERADIGM LLC: PRODUCTS OFFERED
TABLE 496 VERADIGM LLC: PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2026
TABLE 497 VERADIGM LLC: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 498 ATHENAHEALTH: COMPANY OVERVIEW
TABLE 499 ATHENAHEALTH: PRODUCTS OFFERED
TABLE 500 ATHENAHEALTH: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 501 ATHENAHEALTH: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 502 ATHENAHEALTH: OTHER DEVELOPMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 503 GETWELLNETWORK, INC.: COMPANY OVERVIEW
TABLE 504 GETWELLNETWORK, INC.: PRODUCTS OFFERED
TABLE 505 GETWELLNETWORK, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 506 GETWELLNETWORK, INC.: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 507 LINCATA, INC.: COMPANY OVERVIEW
TABLE 508 LINCATA, INC.: PRODUCTS OFFERED
TABLE 509 COGNIZANT: COMPANY OVERVIEW
TABLE 510 COGNIZANT: PRODUCTS OFFERED
TABLE 511 COGNIZANT: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 512 ONEVIEW HEALTHCARE: COMPANY OVERVIEW
TABLE 513 ONEVIEW HEALTHCARE: PRODUCTS OFFERED
TABLE 514 ONEVIEW HEALTHCARE: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 515 ONEVIEW HEALTHCARE: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 516 ONEVIEW HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 517 ADVANCEDMD, INC.: COMPANY OVERVIEW
TABLE 518 ADVANCEDMD, INC.: PRODUCTS OFFERED
TABLE 519 ADVANCEDMD, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 520 ADVANCEDMD, INC.: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 521 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 522 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED
TABLE 523 EPIC SYSTEMS CORPORATION: PRODUCT ENHANCEMENT, JANUARY 2022-FEBRUARY 2026
TABLE 524 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 525 HARRIS HEALTHCARE: COMPANY OVERVIEW
TABLE 526 HARRIS HEALTHCARE: PRODUCTS OFFERED
TABLE 527 HARRIS HEALTHCARE: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 528 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 529 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS OFFERED
TABLE 530 MEDICAL INFORMATION TECHNOLOGY, INC.: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 531 MEDICAL INFORMATION TECHNOLOGY, INC.: OTHER DEVELOPMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 532 TEBRA TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 533 TEBRA TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 534 TEBRA TECHNOLOGIES, INC.: PRODUCT ENHANCEMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 535 TEBRA TECHNOLOGIES, INC.: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 536 TELEVOX: COMPANY OVERVIEW
TABLE 537 TELEVOX: PRODUCTS OFFERED
TABLE 538 TELEVOX: PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2026
TABLE 539 TELEVOX: DEALS, JANUARY 2022-FEBRUARY 2026
TABLE 540 SOLUTIONREACH, INC.: COMPANY OVERVIEW
TABLE 541 SOLUTIONREACH, INC.: PRODUCTS OFFERED
TABLE 542 SOLUTIONREACH, INC.: PRODUCT LAUNCHES AND ENHANCEMENTS, JANUARY 2022-FEBRUARY 2026
TABLE 543 EXPERIAN INFORMATION SOLUTIONS, INC.: COMPANY OVERVIEW
TABLE 544 EXPERIAN INFORMATION SOLUTIONS, INC.: PRODUCTS OFFERED
TABLE 545 ECLINICALWORKS: COMPANY OVERVIEW
TABLE 546 ECLINICALWORKS: PRODUCTS OFFERED
TABLE 547 WELLSTACK: COMPANY OVERVIEW
TABLE 548 RELATIENT: COMPANY OVERVIEW
TABLE 549 LUMA HEALTH INC.: COMPANY OVERVIEW
TABLE 550 CIPHERHEALTH INC.: COMPANY OVERVIEW
TABLE 551 YOSI HEALTH: COMPANY OVERVIEW
TABLE 552 PATIENT ENGAGEMENT SOLUTIONS MARKET: STUDY ASSUMPTIONS
TABLE 553 PATIENT ENGAGEMENT SOLUTIONS MARKET: RISK ANALYSIS

List of Figures

FIGURE 1 PATIENT ENGAGEMENT SOLUTIONS MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 PATIENT ENGAGEMENT SOLUTIONS MARKET: YEARS CONSIDERED
FIGURE 3 PATIENT ENGAGEMENT SOLUTIONS MARKET SCENARIO
FIGURE 4 GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, 2024-2031 (USD BILLION)
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2026
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 7 HIGH-GROWTH SEGMENTS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2026-2031
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PATIENT ENGAGEMENT SOLUTIONS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 9 GROWING ADOPTION OF TELEHEALTH AND REMOTE CARE TO DRIVE MARKET
FIGURE 10 ON-PREMISES AND US TO ACCOUNT FOR LARGEST NORTH AMERICAN PATIENT ENGAGEMENT SOLUTIONS MARKET SHARE IN 2026
FIGURE 11 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 12 PATIENT ENGAGEMENT SOLUTIONS MARKET DYNAMICS
FIGURE 13 PORTER'S FIVE FORCES ANALYSIS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 14 PATIENT ENGAGEMENT SOLUTIONS MARKET: VALUE CHAIN ANALYSIS
FIGURE 15 PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 17 FUNDING (USD MILLION) AND NUMBER OF DEALS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 18 PATENT PUBLICATION TRENDS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2015-2025
FIGURE 19 JURISDICTION AND TOP APPLICANT ANALYSIS FOR PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 20 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR PATIENT ENGAGEMENT SOLUTIONS MARKET (JANUARY 2015 TO DECEMBER 2025)
FIGURE 21 MARKET POTENTIAL OF AI/GEN AI ON PATIENT ENGAGEMENT SOLUTIONS ACROSS INDUSTRIES
FIGURE 22 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
FIGURE 23 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MAJOR END USERS
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 25 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2020-2024 (USD MILLION)
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET (2024)
FIGURE 29 PATIENT ENGAGEMENT SOLUTIONS MARKET: BRAND COMPARITIVE ANALYSIS
FIGURE 30 EV/EBITDA OF KEY VENDORS
FIGURE 31 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 32 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY EVALUATION MATRIX (2025)
FIGURE 33 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY FOOTPRINT
FIGURE 34 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 35 MCKESSON CORPORATION: COMPANY SNAPSHOT
FIGURE 36 ORACLE: COMPANY SNAPSHOT
FIGURE 37 MICROSOFT (NUANCE COMMUNICATIONS, INC.): COMPANY SNAPSHOT
FIGURE 38 TRUBRIDGE: COMPANY SNAPSHOT
FIGURE 39 HEALTH CATALYST: COMPANY SNAPSHOT
FIGURE 40 VERADIGM LLC: COMPANY SNAPSHOT
FIGURE 41 COGNIZANT: COMPANY SNAPSHOT
FIGURE 42 ONEVIEW HEALTHCARE: COMPANY SNAPSHOT
FIGURE 43 EXPERIAN INFORMATION SOLUTIONS, INC.: COMPANY SNAPSHOT
FIGURE 44 PATIENT ENGAGEMENT SOLUTIONS MARKET: RESEARCH DESIGN
FIGURE 45 PATIENT ENGAGEMENT SOLUTIONS MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 46 PATIENT ENGAGEMENT SOLUTIONS MARKET: KEY PRIMARY SOURCES
FIGURE 47 PATIENT ENGAGEMENT SOLUTIONS MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 49 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 50 PATIENT ENGAGEMENT SOLUTIONS MARKET: BOTTOM-UP APPROACH
FIGURE 51 PATIENT ENGAGEMENT SOLUTIONS MARKET: TOP-DOWN APPROACH
FIGURE 52 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF PATIENT ENGAGEMENT SOLUTIONS MARKET
FIGURE 53 PATIENT ENGAGEMENT SOLUTIONS MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)
FIGURE 54 PATIENT ENGAGEMENT SOLUTIONS MARKET: DATA TRIANGULATION METHODOLOGY

Patient Engagement Solutions Market by Therapy, Functionality, End User, Unmet Need, Investment, Market Share, and Trends - Global Forecast to 2030

Description

Table of Contents

List of Tables

Breakdown of supply-side primary interviews, by company type, designation, and region:

TABLE OF CONTENTS

1 INTRODUCTION

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS

4 MARKET OVERVIEW

5 INDUSTRY TRENDS

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

7 REGULATORY LANDSCAPE

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT

10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE

11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION

12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA

13 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY

14 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER

15 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION

16 COMPETITIVE LANDSCAPE

17 COMPANY PROFILES

18 RESEARCH METHODOLOGY

19 APPENDIX

List of Tables

List of Figures